Pharma hub resists Middle East war-driven supply pressuresExecutive summary: The pharmaceutical hub in Centre-Val de Loire is pushing back against pressures arising from the war in the Middle East, affecting drug supply chains. Geopolitical tensions threaten raw material availability and pricing, jeopardizing pharmaceutical production in France and broader European health security. Pharmaceutical companies in the Vallée du médicament, French regulatory authorities, and Middle Eastern conflict actors. Continued geopolitical developments may increase cost pressures, prompting supply chain adjustments and potential policy responses from EU institutions.The French pharmaceutical cluster in Centre-Val de Loire is confronting cost and logistics challenges linked to geopolitical tensions in the Middle East. These pressures stem from disrupted raw material flows and heightened market volatility. The situation underscores the vulnerability of critical supply chains to regional conflict.Connected developmentsOil Prices Rebound as U.S.-Iran Peace Talks Are PostponedLa flambée des prix de l’aluminium fragilise les sous-traitants aéronautiques françaisPlombée par la guerre au Moyen-Orient, l’économie française devrait croître de 0,7% cette année, prévoit l’InseeBourse : pourquoi les marchés financiers résistent au choc de la guerre au Moyen-OrientAu Sri Lanka, la population fait les frais du conflit au Moyen-Orient : « Cette situation n’est plus tenable »Les cours du pétrole chutent de 5% avec l’espoir d’un accord imminent au Moyen-OrientOpen the full case file on Beyond →
Social Pulse
AI estimate · not scraped